Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06362759
PHASE2

A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP

Sponsor: Tourmaline Bio, Inc., a Novartis Company

View on ClinicalTrials.gov

Summary

This study will evaluate the safety, tolerability, pharmacokinetics, and CRP-lowering effect of quarterly and monthly subcutaneous administration of TOUR006 (also known as pacibekitug) in participants with chronic kidney disease and elevated hs-CRP.

Official title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Quarterly and Monthly TOUR006 in Participants With Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

143

Start Date

2024-05-15

Completion Date

2025-12-04

Last Updated

2026-08-11

Healthy Volunteers

No

Interventions

DRUG

TOUR006 - 50 MG

TOUR006 50 MG

DRUG

TOUR006 - 25 MG

TOUR006 25 MG

DRUG

TOUR006 - 15 MG

TOUR006 15 MG

OTHER

Placebo

Placebo

Locations (38)

Site - 0101

Birmingham, Alabama, United States

Site - 0135

Huntsville, Alabama, United States

Site - 0145

Huntsville, Alabama, United States

Site - 0104

Phoenix, Arizona, United States

Site - 0125

San Dimas, California, United States

Site - 0112

Valencia, California, United States

Site - 0128

Valencia, California, United States

Site - 0136

Stamford, Connecticut, United States

Site - 0113

Greenacres City, Florida, United States

Site - 0149

Pembroke Pines, Florida, United States

Site - 0144

Plantation, Florida, United States

Site - 0119

Port Orange, Florida, United States

Site - 0151

Tampa, Florida, United States

Site - 0122

Savannah, Georgia, United States

Site - 0106

Chicago, Illinois, United States

Site - 0115

Morton, Illinois, United States

Site - 0114

Council Bluffs, Iowa, United States

Site - 0129

Metairie, Louisiana, United States

Site - 0123

Las Vegas, Nevada, United States

Site - 0130

Middletown, New York, United States

Site - 0110

Charlotte, North Carolina, United States

Site - 0117

Fargo, North Dakota, United States

Site - 0120

Cincinnati, Ohio, United States

Site - 0127

Marion, Ohio, United States

Site - 0132

Bethlehem, Pennsylvania, United States

Site - 0126

Providence, Rhode Island, United States

Site - 0102

Fort Mill, South Carolina, United States

Site - 0103

Greenville, South Carolina, United States

Site - 0108

Knoxville, Tennessee, United States

Site - 0148

Greenville, Texas, United States

Site - 0105

Houston, Texas, United States

Site - 0111

Lampasas, Texas, United States

Site - 0150

McKinney, Texas, United States

Site - 0107

San Antonio, Texas, United States

Site - 0141

San Antonio, Texas, United States

Site - 0109

Manassas, Virginia, United States

Site - 0147

Morgantown, West Virginia, United States

Site - 0134

Kenosha, Wisconsin, United States